EDGAR Filing Documents for 0001193125-22-303179

Form 8-K - Current report:

SEC Accession No. 0001193125-22-303179

Filing Date

2022-12-13

Accepted

2022-12-13 06:07:18

Documents

Period of Report

2022-12-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d386858d8k.htm iXBRL	8-K	54275
2	EX-10.1	d386858dex101.htm	EX-10.1	298087
3	EX-10.2	d386858dex102.htm	EX-10.2	148953
4	EX-99.1	d386858dex991.htm	EX-99.1	10348
	Complete submission text file	0001193125-22-303179.txt		757965

Data Files

Seq	Description	Document	Type	Size
5	XBRL TAXONOMY EXTENSION SCHEMA	clvs-20221211.xsd	EX-101.SCH	2873
6	XBRL TAXONOMY EXTENSION LABEL LINKBASE	clvs-20221211_lab.xml	EX-101.LAB	17996
7	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	clvs-20221211_pre.xml	EX-101.PRE	11277
9	EXTRACTED XBRL INSTANCE DOCUMENT	d386858d8k_htm.xml	XML	3350

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301

Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000

Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)